News

Muhammad’s Story

by Muhammad Hassan Rasheed Diagnosis I’ve had an eye problem since birth. When I was around four months old, my family noticed something wasn’t right. When I used to crawl, I would bump into things, which made them think I might have a vision issue. They took me to the doctor, and that’s when we [Read More]

New Drug Approved for Treatment of Macular Telangiectasia Type 2 (MacTel)

Neurotech Pharmaceuticals, Inc. has announced FDA approval of ENCELTO (revakinagene taroretcel-lwey) for the treatment of Macular Telangiectasia type 2 (MacTel). ENCELTO is the First and Only FDA-approved first and only treatment for MacTel. MacTel is a neurodegenerative disease of the retina in adults that causes progressive and irreversible vision loss, significantly impacting patients’ quality of [Read More]

1 2 3 119